Intervacc AB
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
IVACC | ST
Overview
Corporate Details
- ISIN(s):
- SE0009607252 (+1 more)
- LEI:
- 549300OICIVZBBZRNZ64
- Country:
- Sweden
- Address:
- Västertorpsvägen 135B, 129 44 Hägersten
- Website:
- https://intervacc.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Intervacc AB is a biotechnology company that develops a new generation of vaccines for animal health. The company utilizes a modern technology platform based on recombinant protein fusions, stemming from research at the Karolinska Institutet and the Swedish University of Agricultural Sciences. Its lead product is Strangvac®, a vaccine against equine strangles. Through its subsidiary Nordvacc, Intervacc has an established sales organization with over 30 years of experience in the European animal health market. Another subsidiary, Mybac-Vettech, provides diagnostic laboratory services. The company's vaccines aim to strengthen animal health and wellbeing while contributing to the reduction of antibiotic use and combating antimicrobial resistance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Intervacc AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Intervacc AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-26 | Lennart Johansson | Other | Other | 813,474 | 691,452.90 SEK |
| 2025-02-21 | Lennart Johansson | Other | Other | 324,156 | 275,532.60 SEK |
